Jarde, A. et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry 73, 826–837 (2016).
Venkatesh, K. K., Ferguson, K. K., Smith, N. A., Cantonwine, D. E. & McElrath, T. F. Association of antenatal depression with clinical subtypes of preterm birth. Am. J. Perinatol. 36, 567–573 (2019).
Grigoriadis, S. et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J. Clin. Psychiatry 74, e321–e341 (2013).
Fekadu Dadi, A., Miller, E. R. & Mwanri, L. Antenatal depression and its association with adverse birth outcomes in low and middle-income countries: a systematic review and meta-analysis. PLoS ONE 15, e0227323 (2020).
Huang, H., Coleman, S., Bridge, J. A., Yonkers, K. & Katon, W. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen. Hosp. Psychiatry 36, 13–18 (2014).
Huybrechts, K. F., Sanghani, R. S., Avorn, J. & Urato, A. C. Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS ONE 9, e92778 (2014).
Ross, L. E. et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70, 436–443 (2013).
Fitton, C. A. et al. In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review. Acta Psychiatr. Scand. 141, 21–33 (2019).
Adhikari, K., Patten, S. B., Lee, S. & Metcalfe, A. Risk of adverse perinatal outcomes among women with pharmacologically treated and untreated depression during pregnancy: a retrospective cohort study. Paediatr. Perinat. Epidemiol. 33, 323–331 (2019).
Corti, S. et al. Neonatal outcomes in maternal depression in relation to intrauterine drug exposure. Front. Pediatr. 7, 309 (2019).
Gelaye, B., Rondon, M. B., Araya, R. & Williams, M. A. Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries. Lancet Psychiatry 3, 973–982 (2016).
Blencowe, H. et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379, 2162–2172 (2012).
Goldenberg, R. L., Culhane, J. F., Iams, J. D. & Romero, R. Epidemiology and causes of preterm birth. Lancet 371, 75–84 (2008).
Nemoda, Z. & Szyf, M. Epigenetic alterations and prenatal maternal depression. Birth Defects Res. 109, 888–897 (2017).
Rakers, F. et al. Transfer of maternal psychosocial stress to the fetus. Neurosci. Biobehav. Rev. https://doi.org/10.1016/j.neubiorev.2017.02.019 (2017).
Kinsella, M. T. & Monk, C. Impact of maternal stress, depression and anxiety on fetal neurobehavioral development. Clin. Obstet. Gynecol. 52, 425–440 (2009).
Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy. 10, Mortality and acute complications in preterm infants. In Preterm Birth: Causes, Consequences, and Prevention (eds Behrman, R. E. & Butler, A. S.) (National Academies Press, Washington, 2007).
Moster, D., Lie, R. T. & Markestad, T. Long-term medical and social consequences of preterm birth. N. Engl. J. Med. 359, 262–273 (2008).
Firth, J. et al. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 18, 308–324 (2019).
Hallahan, B. et al. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. Br. J. Psychiatry 209, 192–201 (2016).
van der Burg, K. P. et al. EPA and DHA as markers of nutraceutical treatment response in major depressive disorder. Eur. J. Nutr. 59, 2439–2447 (2020).
Ciesielski, T. H., Bartlett, J. & Williams, S. M. Omega-3 polyunsaturated fatty acid intake norms and preterm birth rate: a cross-sectional analysis of 184 countries. BMJ Open 9, e027249 (2019).
Bozzatello, P., Rocca, P., Mantelli, E. & Bellino, S. Polyunsaturated fatty acids: what is their role in treatment of psychiatric disorders?. Int. J. Mol. Sci. 20, 5257 (2019).
Appleton, K. M., Sallis, H. M., Perry, R., Ness, A. R. & Churchill, R. Omega-3 fatty acids for depression in adults. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD004692.pub4 (2015).
Middleton, P. et al. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD003402.pub3 (2018).
Makrides, M. et al. A randomized trial of prenatal n-3 fatty acid supplementation and preterm delivery. N. Engl. J. Med. 381, 1035–1045 (2019).
Olsen, S. F. et al. Examining the effect of fish oil supplementation in chinese pregnant women on gestation duration and risk of preterm delivery. J. Nutr. 149, 1942–1951 (2019).
Makrides, M. et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 304, 1675–1683 (2010).
Olsen, S. F. et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 339, 1003–1007 (1992).
Olsen, S. F. et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 107, 382–395 (2000).
Peet, M., Murphy, B., Shay, J. & Horrobin, D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 43, 315–319 (1998).
McNamara, R. K. et al. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J. Affect. Disord. 126, 303–311 (2010).
Riemer, S., Maes, M., Christophe, A. & Rief, W. Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J. Affect. Disord. 123, 173–180 (2010).
Assies, J. et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS ONE 5, e10635 (2010).
Maes, M. et al. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 85, 275–291 (1999).
Lin, P. Y., Chang, C. H., Chong, M. F., Chen, H. & Su, K. P. Polyunsaturated fatty acids in perinatal depression: a systematic review and meta-analysis. Biol. Psychiatry 82, 560–569 (2017).
Olsen, S. F. et al. Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth. EBioMedicine 35, 325–333 (2018).
Olsen, S. F. et al. Corrigendum to ‘Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth’. EBioMedicine 51, 102619 (2020).
Grosso, G. et al. Dietary n-3 PUFA, fish consumption and depression: a systematic review and meta-analysis of observational studies. J. Affect. Disord. 205, 269–281 (2016).
Golding, J., Steer, C., Emmett, P., Davis, J. M. & Hibbeln, J. R. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 20, 598–603 (2009).
Olsen, S. F. et al. Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 2, 367–369 (1986).
Ciesielski, T. H. n-3 and preterm birth: what can we learn from the heterogeneity?. Public Health Nutr. 23, 2453–2454 (2020).
Grosso, G. et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid. Med. Cell Longev. 2014, 313570 (2014).
Larrieu, T. & Laye, S. Food for mood: relevance of nutritional omega-3 fatty acids for depression and anxiety. Front. Physiol. 9, 1047 (2018).
Burhani, M. D. & Rasenick, M. M. Fish oil and depression: the skinny on fats. J. Integr. Neurosci. 16, S115-s124 (2017).
Facchinetti, F., Fazzio, M. & Venturini, P. Polyunsaturated fatty acids and risk of preterm delivery. Eur. Rev. Med. Pharmacol. Sci. 9, 41–48 (2005).
Chen, C. Y., Chen, C. Y., Liu, C. C. & Chen, C. P. Omega-3 polyunsaturated fatty acids reduce preterm labor by inhibiting trophoblast cathepsin S and inflammasome activation. Clin. Sci. 132, 2221–2239 (2018).
Elliott, E., Hanson, C. K., Anderson-Berry, A. L. & Nordgren, T. M. The role of specialized pro-resolving mediators in maternal-fetal health. Prostaglandins Leukot Essent Fat. Acids 126, 98–104 (2017).
Liu, L. et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151–2161 (2012).
Grosse, S. D., Waitzman, N. J., Yang, N., Abe, K. & Barfield, W. D. Employer-sponsored plan expenditures for infants born preterm. Pediatrics 140, e20171078 (2017).
McLaurin, K. K. et al. Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US. Pediatr. Health Med. Ther. 10, 21–31 (2019).
Ferrari, A. J. et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 10, e1001547 (2013).
Konig, H., Konig, H. H. & Konnopka, A. The excess costs of depression: a systematic review and meta-analysis. Epidemiol. Psychiatr. Sci. 29, 1–16 (2020).
Institute of Medicine (US) Roundtable on Environmental Health Sciences. 1, Preterm birth and its consequences. In The Role of Environmental Hazards in Premature Birth: Workshop Summary (eds Donald, R. & Mattison, S. W.) (National Academies Press, Washington, 2003).
Frey, H. A. & Klebanoff, M. A. The epidemiology, etiology, and costs of preterm birth. Semin. Fetal Neonatal Med. 21, 68–73 (2016).
Micha, R. et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ 348, g2272 (2014).
Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ 350, h1702. https://doi.org/10.1136/bmj.h1702 (2015).
Ferrari, A. J. et al. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS ONE 8, e69637 (2013).
Vos, T. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163–2196 (2012).
World-Health-Organization. The ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines (World Health Organization, Geneva, 1992).
Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260 (2012).
Micha, R. et al. Estimating the global and regional burden of suboptimal nutrition on chronic disease: methods and inputs to the analysis. Eur. J. Clin. Nutr. 66, 119–129 (2012).
Burdge, G. C. & Wootton, S. A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 88, 411–420 (2002).
Burdge, G. C., Jones, A. E. & Wootton, S. A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*. Br. J. Nutr. 88, 355–363 (2002).
Calder, P. C. Docosahexaenoic acid. Ann. Nutr. Metab. 69(Suppl 1), 7–21 (2016).
Innis, S. M. Omega-3 fatty acid biochemistry: perspectives from human nutrition. Mil. Med. 179, 82–87 (2014).
Schmitz, G. & Ecker, J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 47, 147–155 (2008).
Ameur, A. et al. Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids. Am. J. Hum. Genet. 90, 809–820 (2012).
Zhang, J. Y., Kothapalli, K. S. & Brenna, J. T. Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis. Curr. Opin. Clin. Nutr. Metab. Care 19, 103–110 (2016).
Wood, S. N. Package ’mgcv’ (Accessed 1 November 2020); https://cran.r-project.org/web/packages/mgcv/mgcv.pdf.
Craven, P. & Wahba, G. Smoothing noisy data with spline functions – estimating the correct degree of smoothing by the method of generalized cross-validation. Numer. Math. 31, 377–403 (1979).
Ciesielski, T. H., Marsit, C. J. & Williams, S. M. Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth. BMC Pregnancy Childbirth 15, 192 (2015).
Szegda, K., Markenson, G., Bertone-Johnson, E. R. & Chasan-Taber, L. Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J. Matern. Fetal Neonatal Med. 27, 960–967 (2013).
Bai, S. et al. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. J. Neurol. Neurosurg. Psychiatry 91, 21–32 (2020).
Liao, Y. et al. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Transl. Psychiatry 9, 190 (2019).
Ciesielski, T. H. et al. Diverse convergent evidence in the genetic analysis of complex disease: coordinating omic, informatic, and experimental evidence to better identify and validate risk factors. BioData Min. 7, 10 (2014).
Gananca, L. et al. Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: a pilot study. Prostaglandins Leukot Essent Fat. Acids 119, 38–44 (2017).
Meyer, B. J. et al. Improvement of major depression is associated with increased erythrocyte DHA. Lipids 48, 863–868 (2013).
Hoge, A. et al. Impact of erythrocyte long-chain omega-3 polyunsaturated fatty acid levels in early pregnancy on birth outcomes: findings from a Belgian cohort study. J. Perinatol. 40, 488–496 (2020).
Jackson, K. H. & Harris, W. S. A prenatal DHA test to help identify women at increased risk for early preterm birth: a proposal. Nutrients 10, 1933 (2018).
Rothman, K. J. Causes. Am. J. Epidemiol. 104, 587–592 (1976).
Howards, P. P. An overview of confounding. Part 2: how to identify it and special situations. Acta Obstet. Gynecol. Scand. 97, 400–406 (2018).
Suttorp, M. M., Siegerink, B., Jager, K. J., Zoccali, C. & Dekker, F. W. Graphical presentation of confounding in directed acyclic graphs. Nephrol. Dial. Transpl. 30, 1418–1423 (2015).
Bloomfield, F. H. How is maternal nutrition related to preterm birth?. Annu. Rev. Nutr. 31, 235–261 (2011).
Zhou, S. S., Tao, Y. H., Huang, K., Zhu, B. B. & Tao, F. B. Vitamin D and risk of preterm birth: up-to-date meta-analysis of randomized controlled trials and observational studies. J. Obstet. Gynaecol. Res. 43, 247–256 (2017).
Ferguson, K. K., O’Neill, M. S. & Meeker, J. D. Environmental contaminant exposures and preterm birth: a comprehensive review. J. Toxicol. Environ. Health B Crit. Rev. 16, 69–113 (2013).
van den Bosch, M. & Meyer-Lindenberg, A. Environmental exposures and depression: biological mechanisms and epidemiological evidence. Annu. Rev. Public Health 40, 239–259 (2019).
Rautio, N., Filatova, S., Lehtiniemi, H. & Miettunen, J. Living environment and its relationship to depressive mood: a systematic review. Int. J. Soc. Psychiatry 64, 92–103 (2018).
Bender, A., Hagan, K. E. & Kingston, N. The association of folate and depression: a meta-analysis. J. Psychiatr. Res. 95, 9–18 (2017).
Zhang, Q. et al. Effect of folic acid supplementation on preterm delivery and small for gestational age births: a systematic review and meta-analysis. Reprod. Toxicol. 67, 35–41 (2017).
Jamilian, H. et al. The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: a systematic review and meta-analysis of randomized controlled trials. Prog. Neuropsychopharmacol. Biol. Psychiatry 94, 109651 (2019).
Schisterman, E. F., Cole, S. R. & Platt, R. W. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiol. Camb. Mass 20, 488–495 (2009).
Howards, P. P., Schisterman, E. F. & Heagerty, P. J. Potential confounding by exposure history and prior outcomes: an example from perinatal epidemiology. Epidemiology 18, 544–551 (2007).
Wilson, N. A., Mantzioris, E., Middleton, P. T. & Muhlhausler, B. S. Gestational age and maternal status of DHA and other polyunsaturated fatty acids in pregnancy: A systematic review. Prostaglandins Leukot. Essent. Fatty Acids 144, 16–31 (2019).
Wilson, N. A., Mantzioris, E., Middleton, P. F. & Muhlhausler, B. S. Influence of sociodemographic, lifestyle and genetic characteristics on maternal DHA and other polyunsaturated fatty acid status in pregnancy: a systematic review. Prostaglandins Leukot. Essent. Fatty Acids 152, 102037 (2020).
Wilson, N. A., Mantzioris, E., Middleton, P. F. & Muhlhausler, B. S. Influence of clinical characteristics on maternal DHA and other polyunsaturated fatty acid status in pregnancy: a systematic review. Prostaglandins Leukot. Essent. Fatty Acids 154, 102063 (2020).
Sparkes, C., Sinclair, A. J., Gibson, R. A., Else, P. L. & Meyer, B. J. High variability in erythrocyte, plasma and whole blood EPA and DHA levels in response to supplementation. Nutrients 12, 1017 (2020).
Zemdegs, J. et al. Anxiolytic- and antidepressant-like effects of fish oil-enriched diet in brain-derived neurotrophic factor deficient mice. Front. Neurosci. 12, 974 (2018).
Yamashita, A. et al. Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth. Sci. Rep. 3, 3113 (2013).
Pearce, N. The ecological fallacy strikes back. J. Epidemiol. Commun. Health 54, 326–327 (2000).
Morgenstern, H. Ecologic studies in epidemiology: concepts, principles, and methods. Annu. Rev. Public Health 16, 61–81 (1995).
Ciesielski, T. H., Aldrich, M. C., Marsit, C. J., Hiatt, R. A. & Williams, S. M. Transdisciplinary approaches enhance the production of translational knowledge. Transl. Res. 182, 123–134 (2017).
Source: Ecology - nature.com
